author_facet Prizment, Anna E.
Vierkant, Robert A.
Smyrk, Thomas C.
Tillmans, Lori S.
Nelson, Heather H.
Lynch, Charles F.
Pengo, Thomas
Thibodeau, Stephen N.
Church, Timothy R.
Cerhan, James R.
Anderson, Kristin E.
Limburg, Paul J.
Prizment, Anna E.
Vierkant, Robert A.
Smyrk, Thomas C.
Tillmans, Lori S.
Nelson, Heather H.
Lynch, Charles F.
Pengo, Thomas
Thibodeau, Stephen N.
Church, Timothy R.
Cerhan, James R.
Anderson, Kristin E.
Limburg, Paul J.
author Prizment, Anna E.
Vierkant, Robert A.
Smyrk, Thomas C.
Tillmans, Lori S.
Nelson, Heather H.
Lynch, Charles F.
Pengo, Thomas
Thibodeau, Stephen N.
Church, Timothy R.
Cerhan, James R.
Anderson, Kristin E.
Limburg, Paul J.
spellingShingle Prizment, Anna E.
Vierkant, Robert A.
Smyrk, Thomas C.
Tillmans, Lori S.
Nelson, Heather H.
Lynch, Charles F.
Pengo, Thomas
Thibodeau, Stephen N.
Church, Timothy R.
Cerhan, James R.
Anderson, Kristin E.
Limburg, Paul J.
Cancer Epidemiology, Biomarkers & Prevention
Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
Oncology
Epidemiology
author_sort prizment, anna e.
spelling Prizment, Anna E. Vierkant, Robert A. Smyrk, Thomas C. Tillmans, Lori S. Nelson, Heather H. Lynch, Charles F. Pengo, Thomas Thibodeau, Stephen N. Church, Timothy R. Cerhan, James R. Anderson, Kristin E. Limburg, Paul J. 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-16-0641 <jats:title>Abstract</jats:title> <jats:p>Background: Host immune response may predict the course of colorectal cancer. We examined the survival of 468 colorectal cancer patients associated with two tumor-infiltrating immune biomarkers, the number of cytotoxic T lymphocytes (CTLs), and the activated CTLs, as reflected by the number of cells expressing granzyme B (GZMB) in the prospective Iowa Women's Health Study.</jats:p> <jats:p>Methods: Using paraffin-embedded tissue samples, we constructed and immunostained tumor microarrays with CD8 (for CTL) and GZMB antibodies. We scored CTL and GZMB densities in tumor epithelial and stromal tissues and also created a composite score for each biomarker (sum of the scores across tissue compartments). Cox regression estimated the HR and 95% confidence intervals (CI) for all-cause and colorectal cancer–specific death associated with each composite score.</jats:p> <jats:p>Results: CTL and GZMB composite scores were positively correlated (r = 0.65) and each biomarker was inversely correlated with stage at diagnosis. Both composite scores were higher in proximal colon tumors and tumors characterized by MSI-high, CIMP-high, or BRAF mutation status. HRs (95% CI) were 0.53 (0.38–0.75; Ptrend = 0.0004) and 0.66 (0.51–0.86; Ptrend = 0.002) for all-cause death, respectively, and 0.30 (0.18–0.51; Ptrend &amp;lt; 0.0001) and 0.41 (0.27–0.63; Ptrend &amp;lt; 0.0001) for colorectal cancer–related death, respectively. Including CTL and GZMB scores simultaneously in the model significantly improved the predictive performance of the models for all-cause and colorectal cancer–related death.</jats:p> <jats:p>Conclusions: Higher tumor infiltration with CTL and GZMB cells is associated with improved all-cause and cancer-specific survival of colorectal cancer patients.</jats:p> <jats:p>Impact: Both the number of CTLs and GZMB appear to be useful prognostic factors in colorectal cancer, irrespective of stage. Cancer Epidemiol Biomarkers Prev; 26(4); 622–31. ©2016 AACR.</jats:p> Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women Cancer Epidemiology, Biomarkers & Prevention
doi_str_mv 10.1158/1055-9965.epi-16-0641
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTE2LTA2NDE
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTE2LTA2NDE
institution DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Zwi2
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
imprint American Association for Cancer Research (AACR), 2017
imprint_str_mv American Association for Cancer Research (AACR), 2017
issn 1055-9965
1538-7755
issn_str_mv 1055-9965
1538-7755
language English
mega_collection American Association for Cancer Research (AACR) (CrossRef)
match_str prizment2017cytotoxictcellsandgranzymebassociatedwithimprovedcolorectalcancersurvivalinaprospectivecohortofolderwomen
publishDateSort 2017
publisher American Association for Cancer Research (AACR)
recordtype ai
record_format ai
series Cancer Epidemiology, Biomarkers & Prevention
source_id 49
title Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
title_unstemmed Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
title_full Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
title_fullStr Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
title_full_unstemmed Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
title_short Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
title_sort cytotoxic t cells and granzyme b associated with improved colorectal cancer survival in a prospective cohort of older women
topic Oncology
Epidemiology
url http://dx.doi.org/10.1158/1055-9965.epi-16-0641
publishDate 2017
physical 622-631
description <jats:title>Abstract</jats:title> <jats:p>Background: Host immune response may predict the course of colorectal cancer. We examined the survival of 468 colorectal cancer patients associated with two tumor-infiltrating immune biomarkers, the number of cytotoxic T lymphocytes (CTLs), and the activated CTLs, as reflected by the number of cells expressing granzyme B (GZMB) in the prospective Iowa Women's Health Study.</jats:p> <jats:p>Methods: Using paraffin-embedded tissue samples, we constructed and immunostained tumor microarrays with CD8 (for CTL) and GZMB antibodies. We scored CTL and GZMB densities in tumor epithelial and stromal tissues and also created a composite score for each biomarker (sum of the scores across tissue compartments). Cox regression estimated the HR and 95% confidence intervals (CI) for all-cause and colorectal cancer–specific death associated with each composite score.</jats:p> <jats:p>Results: CTL and GZMB composite scores were positively correlated (r = 0.65) and each biomarker was inversely correlated with stage at diagnosis. Both composite scores were higher in proximal colon tumors and tumors characterized by MSI-high, CIMP-high, or BRAF mutation status. HRs (95% CI) were 0.53 (0.38–0.75; Ptrend = 0.0004) and 0.66 (0.51–0.86; Ptrend = 0.002) for all-cause death, respectively, and 0.30 (0.18–0.51; Ptrend &amp;lt; 0.0001) and 0.41 (0.27–0.63; Ptrend &amp;lt; 0.0001) for colorectal cancer–related death, respectively. Including CTL and GZMB scores simultaneously in the model significantly improved the predictive performance of the models for all-cause and colorectal cancer–related death.</jats:p> <jats:p>Conclusions: Higher tumor infiltration with CTL and GZMB cells is associated with improved all-cause and cancer-specific survival of colorectal cancer patients.</jats:p> <jats:p>Impact: Both the number of CTLs and GZMB appear to be useful prognostic factors in colorectal cancer, irrespective of stage. Cancer Epidemiol Biomarkers Prev; 26(4); 622–31. ©2016 AACR.</jats:p>
container_issue 4
container_start_page 622
container_title Cancer Epidemiology, Biomarkers & Prevention
container_volume 26
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792348699076067334
geogr_code not assigned
last_indexed 2024-03-01T18:15:19.851Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Cytotoxic+T+Cells+and+Granzyme+B+Associated+with+Improved+Colorectal+Cancer+Survival+in+a+Prospective+Cohort+of+Older+Women&rft.date=2017-04-01&genre=article&issn=1538-7755&volume=26&issue=4&spage=622&epage=631&pages=622-631&jtitle=Cancer+Epidemiology%2C+Biomarkers+%26+Prevention&atitle=Cytotoxic+T+Cells+and+Granzyme+B+Associated+with+Improved+Colorectal+Cancer+Survival+in+a+Prospective+Cohort+of+Older+Women&aulast=Limburg&aufirst=Paul+J.&rft_id=info%3Adoi%2F10.1158%2F1055-9965.epi-16-0641&rft.language%5B0%5D=eng
SOLR
_version_ 1792348699076067334
author Prizment, Anna E., Vierkant, Robert A., Smyrk, Thomas C., Tillmans, Lori S., Nelson, Heather H., Lynch, Charles F., Pengo, Thomas, Thibodeau, Stephen N., Church, Timothy R., Cerhan, James R., Anderson, Kristin E., Limburg, Paul J.
author_facet Prizment, Anna E., Vierkant, Robert A., Smyrk, Thomas C., Tillmans, Lori S., Nelson, Heather H., Lynch, Charles F., Pengo, Thomas, Thibodeau, Stephen N., Church, Timothy R., Cerhan, James R., Anderson, Kristin E., Limburg, Paul J., Prizment, Anna E., Vierkant, Robert A., Smyrk, Thomas C., Tillmans, Lori S., Nelson, Heather H., Lynch, Charles F., Pengo, Thomas, Thibodeau, Stephen N., Church, Timothy R., Cerhan, James R., Anderson, Kristin E., Limburg, Paul J.
author_sort prizment, anna e.
container_issue 4
container_start_page 622
container_title Cancer Epidemiology, Biomarkers & Prevention
container_volume 26
description <jats:title>Abstract</jats:title> <jats:p>Background: Host immune response may predict the course of colorectal cancer. We examined the survival of 468 colorectal cancer patients associated with two tumor-infiltrating immune biomarkers, the number of cytotoxic T lymphocytes (CTLs), and the activated CTLs, as reflected by the number of cells expressing granzyme B (GZMB) in the prospective Iowa Women's Health Study.</jats:p> <jats:p>Methods: Using paraffin-embedded tissue samples, we constructed and immunostained tumor microarrays with CD8 (for CTL) and GZMB antibodies. We scored CTL and GZMB densities in tumor epithelial and stromal tissues and also created a composite score for each biomarker (sum of the scores across tissue compartments). Cox regression estimated the HR and 95% confidence intervals (CI) for all-cause and colorectal cancer–specific death associated with each composite score.</jats:p> <jats:p>Results: CTL and GZMB composite scores were positively correlated (r = 0.65) and each biomarker was inversely correlated with stage at diagnosis. Both composite scores were higher in proximal colon tumors and tumors characterized by MSI-high, CIMP-high, or BRAF mutation status. HRs (95% CI) were 0.53 (0.38–0.75; Ptrend = 0.0004) and 0.66 (0.51–0.86; Ptrend = 0.002) for all-cause death, respectively, and 0.30 (0.18–0.51; Ptrend &amp;lt; 0.0001) and 0.41 (0.27–0.63; Ptrend &amp;lt; 0.0001) for colorectal cancer–related death, respectively. Including CTL and GZMB scores simultaneously in the model significantly improved the predictive performance of the models for all-cause and colorectal cancer–related death.</jats:p> <jats:p>Conclusions: Higher tumor infiltration with CTL and GZMB cells is associated with improved all-cause and cancer-specific survival of colorectal cancer patients.</jats:p> <jats:p>Impact: Both the number of CTLs and GZMB appear to be useful prognostic factors in colorectal cancer, irrespective of stage. Cancer Epidemiol Biomarkers Prev; 26(4); 622–31. ©2016 AACR.</jats:p>
doi_str_mv 10.1158/1055-9965.epi-16-0641
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTE2LTA2NDE
imprint American Association for Cancer Research (AACR), 2017
imprint_str_mv American Association for Cancer Research (AACR), 2017
institution DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1
issn 1055-9965, 1538-7755
issn_str_mv 1055-9965, 1538-7755
language English
last_indexed 2024-03-01T18:15:19.851Z
match_str prizment2017cytotoxictcellsandgranzymebassociatedwithimprovedcolorectalcancersurvivalinaprospectivecohortofolderwomen
mega_collection American Association for Cancer Research (AACR) (CrossRef)
physical 622-631
publishDate 2017
publishDateSort 2017
publisher American Association for Cancer Research (AACR)
record_format ai
recordtype ai
series Cancer Epidemiology, Biomarkers & Prevention
source_id 49
spelling Prizment, Anna E. Vierkant, Robert A. Smyrk, Thomas C. Tillmans, Lori S. Nelson, Heather H. Lynch, Charles F. Pengo, Thomas Thibodeau, Stephen N. Church, Timothy R. Cerhan, James R. Anderson, Kristin E. Limburg, Paul J. 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-16-0641 <jats:title>Abstract</jats:title> <jats:p>Background: Host immune response may predict the course of colorectal cancer. We examined the survival of 468 colorectal cancer patients associated with two tumor-infiltrating immune biomarkers, the number of cytotoxic T lymphocytes (CTLs), and the activated CTLs, as reflected by the number of cells expressing granzyme B (GZMB) in the prospective Iowa Women's Health Study.</jats:p> <jats:p>Methods: Using paraffin-embedded tissue samples, we constructed and immunostained tumor microarrays with CD8 (for CTL) and GZMB antibodies. We scored CTL and GZMB densities in tumor epithelial and stromal tissues and also created a composite score for each biomarker (sum of the scores across tissue compartments). Cox regression estimated the HR and 95% confidence intervals (CI) for all-cause and colorectal cancer–specific death associated with each composite score.</jats:p> <jats:p>Results: CTL and GZMB composite scores were positively correlated (r = 0.65) and each biomarker was inversely correlated with stage at diagnosis. Both composite scores were higher in proximal colon tumors and tumors characterized by MSI-high, CIMP-high, or BRAF mutation status. HRs (95% CI) were 0.53 (0.38–0.75; Ptrend = 0.0004) and 0.66 (0.51–0.86; Ptrend = 0.002) for all-cause death, respectively, and 0.30 (0.18–0.51; Ptrend &amp;lt; 0.0001) and 0.41 (0.27–0.63; Ptrend &amp;lt; 0.0001) for colorectal cancer–related death, respectively. Including CTL and GZMB scores simultaneously in the model significantly improved the predictive performance of the models for all-cause and colorectal cancer–related death.</jats:p> <jats:p>Conclusions: Higher tumor infiltration with CTL and GZMB cells is associated with improved all-cause and cancer-specific survival of colorectal cancer patients.</jats:p> <jats:p>Impact: Both the number of CTLs and GZMB appear to be useful prognostic factors in colorectal cancer, irrespective of stage. Cancer Epidemiol Biomarkers Prev; 26(4); 622–31. ©2016 AACR.</jats:p> Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women Cancer Epidemiology, Biomarkers & Prevention
spellingShingle Prizment, Anna E., Vierkant, Robert A., Smyrk, Thomas C., Tillmans, Lori S., Nelson, Heather H., Lynch, Charles F., Pengo, Thomas, Thibodeau, Stephen N., Church, Timothy R., Cerhan, James R., Anderson, Kristin E., Limburg, Paul J., Cancer Epidemiology, Biomarkers & Prevention, Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women, Oncology, Epidemiology
title Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
title_full Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
title_fullStr Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
title_full_unstemmed Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
title_short Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
title_sort cytotoxic t cells and granzyme b associated with improved colorectal cancer survival in a prospective cohort of older women
title_unstemmed Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
topic Oncology, Epidemiology
url http://dx.doi.org/10.1158/1055-9965.epi-16-0641